Stevanato Group (STVN) Competitors €21.75 -0.10 (-0.46%) As of 08/12/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STVN vs. PHG, ZBH, SNN, SOLV, PEN, IRTC, GKOS, BLCO, SLNO, and TMDXShould you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Stevanato Group vs. Its Competitors Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra iRhythm Technologies Glaukos Bausch + Lomb Soleno Therapeutics TransMedics Group Koninklijke Philips (NYSE:PHG) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk. Which has more volatility & risk, PHG or STVN? Koninklijke Philips has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Is PHG or STVN more profitable? Stevanato Group has a net margin of 11.73% compared to Koninklijke Philips' net margin of 1.00%. Koninklijke Philips' return on equity of 11.95% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets Koninklijke Philips1.00% 11.95% 4.94% Stevanato Group 11.73%10.34%6.21% Do analysts prefer PHG or STVN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the media refer more to PHG or STVN? In the previous week, Stevanato Group had 11 more articles in the media than Koninklijke Philips. MarketBeat recorded 16 mentions for Stevanato Group and 5 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.11 beat Stevanato Group's score of 0.68 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, PHG or STVN? Stevanato Group has lower revenue, but higher earnings than Koninklijke Philips. Stevanato Group is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKoninklijke Philips$19.50B1.33-$758.55M$0.19142.00Stevanato Group€1.19B5.51€127.45M€0.5440.28 Do insiders & institutionals believe in PHG or STVN? 13.7% of Koninklijke Philips shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryKoninklijke Philips and Stevanato Group tied by winning 7 of the 14 factors compared between the two stocks. Get Stevanato Group News Delivered to You Automatically Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STVN vs. The Competition Export to ExcelMetricStevanato GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap€6.59B€2.42B€5.49B€20.65BDividend YieldN/A1.81%4.64%3.65%P/E Ratio40.2821.6530.3828.37Price / Sales5.51685.10451.9960.24Price / Cash28.94186.7137.7222.93Price / Book4.154.408.305.38Net Income€127.45M€31.61M€3.26B€994.60M7 Day Performance-9.79%0.96%1.54%1.47%1 Month Performance-13.55%2.34%3.74%0.48%1 Year Performance5.07%5.33%40.92%14.95% Stevanato Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STVNStevanato GroupN/A€21.75-0.5%N/A+9.2%€6.59B€1.19B40.285,521Gap DownPHGKoninklijke Philips3.6324 of 5 stars$26.68-0.6%N/A-4.8%$25.84B$19.50B140.3966,678Positive NewsZBHZimmer Biomet4.6018 of 5 stars$99.95+0.7%$111.44+11.5%-4.9%$19.66B$7.68B24.3217,000Earnings ReportAnalyst RevisionSNNSmith & Nephew SNATS2.2559 of 5 stars$35.96-0.5%$28.00-22.1%+23.0%$15.83B$5.81B16.6517,349Positive NewsDividend CutSOLVSolventum2.2036 of 5 stars$71.89-2.0%$85.75+19.3%+24.8%$12.70B$8.25B33.2822,000News CoverageEarnings ReportPENPenumbra4.7461 of 5 stars$239.79-0.3%$300.47+25.3%+47.8%$9.38B$1.19B63.774,500Positive NewsIRTCiRhythm Technologies1.7856 of 5 stars$160.56+1.3%$157.30-2.0%+151.2%$5.09B$591.84M-54.802,000Insider TradeGKOSGlaukos3.9931 of 5 stars$86.94+2.7%$127.42+46.6%-26.5%$4.85B$383.48M-52.69780Positive NewsBLCOBausch + Lomb2.8289 of 5 stars$13.66+0.1%$15.56+13.9%-11.4%$4.83B$4.79B-17.5113,500SLNOSoleno Therapeutics4.6057 of 5 stars$85.76+4.1%$113.30+32.1%+78.0%$4.38BN/A-20.7130Earnings ReportAnalyst RevisionTMDXTransMedics Group2.296 of 5 stars$127.26+11.1%$123.00-3.3%-19.6%$3.90B$441.54M65.94210 Related Companies and Tools Related Companies PHG Alternatives ZBH Alternatives SNN Alternatives SOLV Alternatives PEN Alternatives IRTC Alternatives GKOS Alternatives BLCO Alternatives SLNO Alternatives TMDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:STVN) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access